Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 43 pharmaceuticals ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 12:44 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- First
- Royalty Pharma65.6%
- Median
- 12.5%
- Combined market value
- PLN 20.77T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | PLN 159B | PLN 276.52 | 0.23% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | PLN 20.3B | PLN 243.02 | 1.00% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | PLN 100.2B | PLN 2,351.68 | 0.64% down | 23% up | ||
| 4 | Novo NordiskNVO · Health Care | 41.3% | PLN 722.2B | PLN 163.86 | 2.16% down | 17% down | ||
| 5 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | PLN 545.3B | PLN 2,150.77 | 0.67% down | 27% up | ||
| 6 | NovartisNVS · Health Care | 32.4% | PLN 1.21T | PLN 640.68 | 0.67% down | 25% up | ||
| 7 | GenmabGMAB · Health Care | 28.6% | PLN 129B | PLN 209.20 | 0.76% up | 70% up | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | PLN 398.9B | PLN 3,856.10 | 0.56% up | 36% up | ||
| 9 | AbbVieABBV · Health Care | 24.6% | PLN 2.08T | PLN 1,178.94 | 0.59% down | 26% up | ||
| 10 | GSKGSK · Health Care | 24.3% | PLN 397.4B | PLN 198.25 | 2.32% down | 6% up | ||
| 11 | AstraZenecaAZN · Health Care | 23.4% | PLN 1.14T | PLN 733.85 | 0.95% down | 2% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 20.0% | PLN 38.2B | PLN 252.48 | 0.08% down | 107% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | 18.2% | PLN 730.2B | PLN 421.58 | 2.55% down | 17% down | ||
| 14 | AlkermesALKS · Health Care | 17.2% | PLN 30.8B | PLN 182.99 | 2.32% down | 58% up | ||
| 15 | GrifolsGRFS · Health Care | 16.5% | PLN 23.6B | PLN 34.75 | 1.15% down | 1% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | PLN 23.7B | PLN 1,182.93 | 2.62% down | 43% up | ||
| 17 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | PLN 49.6B | PLN 59.55 | 0.61% up | 5% up | ||
| 18 | SanofiSNY · Health Care | 14.5% | PLN 459.5B | PLN 191.36 | 1.78% down | 4% down | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | PLN 84.4B | PLN 630.09 | 2.02% down | 66% down | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | PLN 29.6B | PLN 85.03 | 0.52% down | 83% up | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | PLN 45.6B | PLN 235.57 | 0.90% up | 11% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | PLN 200.2B | PLN 171.59 | 0.12% up | 74% up | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | PLN 24.5B | PLN 173.08 | 2.76% down | 10% up | ||
| 24 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | PLN 30.1B | PLN 382.93 | 0.93% up | 126% up | ||
| 25 | BeOne MedicinesONC · Health Care | 8.37% | PLN 190.1B | PLN 1,663.85 | 0.48% up | 17% up | ||
| 26 | Corcept TherapeuticsCORT · Health Care | 5.88% | PLN 30.9B | PLN 282.11 | 1.23% up | 8% down | ||
| 27 | Takeda PharmaceuticalTAK · Health Care | 0.14% | PLN 278.4B | PLN 87.13 | 0.23% up | 54% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | PLN 24.2B | PLN 370.21 | 0.40% up | 31% up | ||
| 29 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | PLN 62.2B | PLN 969.14 | 0.39% up | 37% up | ||
| 30 | Travere TherapeuticsTVTX · Health Care | -12.8% | PLN 19.7B | PLN 205.74 | 2.82% up | 44% up | ||
| 31 | Legend BiotechLEGN · Health Care | -13.3% | PLN 12.6B | PLN 64.86 | 0.75% up | 42% down | ||
| 32 | ViatrisVTRS · Health Care | -18.6% | PLN 94.4B | PLN 82.33 | 1.40% down | 96% up | ||
| 33 | Ascendis PharmaASND · Health Care | -18.9% | PLN 71.6B | PLN 1,091.85 | 0.20% down | 28% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | -26.1% | PLN 28.8B | PLN 547.36 | 0.77% down | 7% down | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | PLN 39.5B | PLN 1,699.00 | 0.46% down | 24% down | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | PLN 18.1B | PLN 108.55 | 3.75% down | 64% down | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | PLN 32.6B | PLN 469.49 | 8.49% up | 13% up | ||
| 38 | BridgeBio PharmaBBIO · Health Care | -104% | PLN 60.2B | PLN 309.21 | 0.72% down | 17% up | ||
| 39 | InsmedINSM · Health Care | -206% | PLN 107.6B | PLN 490.63 | 0.83% down | 40% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | -344% | PLN 32.8B | PLN 501.94 | 0.13% down | 46% up | ||
| 41 | CytokineticsCYTK · Health Care | -695% | PLN 29B | PLN 207.95 | 2.86% down | 20% down | ||
| 42 | Roivant SciencesROIV · Health Care | -6236% | PLN 112.9B | PLN 155.85 | 0.26% up | 90% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | -8739% | PLN 19.7B | PLN 350.20 | 2.87% down | 113% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0262 PLN). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 43 pharmaceuticals ranked by operating margin as of 18 Nov 2026, 12:44 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of PLN 20.77T as of 18 Nov 2026, 12:44 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.